aluates Reports

$ 0.0

Automative

Global Natural Killer (NK) Cell Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-5C13853

Global Natural Killer NK Cell Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Natural Killer (NK) Cell Therapeutics Market Research Report 2025

Code: QYRE-Auto-5C13853

Report

September 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Chipscreen Biosciences

Affimed NV

Altor Bioscience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

Natural Killer (NK) Cell Therapeutics Market Size

The global market for Natural Killer (NK) Cell Therapeutics was valued at US$ 274 million in the year 2024 and is projected to reach a revised size of US$ 345 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Natural Killer (NK) Cell Therapeutics Market

Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

This report aims to provide a comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer (NK) Cell Therapeutics.

The Natural Killer (NK) Cell Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer (NK) Cell Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Natural Killer (NK) Cell Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Natural Killer (NK) Cell Therapeutics Market Report

Report Metric	Details
Report Name	Natural Killer (NK) Cell Therapeutics Market
Accounted market size in year	US$ 274 million
Forecasted market size in 2031	US$ 345 million
CAGR	3.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Mogamulizumab Lorvotuzumab Mertansine Others
Segment by Application	Cancer Cardiovascular Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer (NK) Cell Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Natural Killer (NK) Cell Therapeutics Market growing?

Ans: The Natural Killer (NK) Cell Therapeutics Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Natural Killer (NK) Cell Therapeutics Market size in 2031?

Ans: The Natural Killer (NK) Cell Therapeutics Market size in 2031 will be US$ 345 million.

What is the Natural Killer (NK) Cell Therapeutics Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the Natural Killer (NK) Cell Therapeutics Market share by application?

Ans: The cancer segment accounted for a major share in 2019 (66.99%).

What is the market share of major companies in Natural Killer (NK) Cell Therapeutics Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Who are the main players in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The main players in the Natural Killer (NK) Cell Therapeutics Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services

What are the Application segmentation covered in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The Applications covered in the Natural Killer (NK) Cell Therapeutics Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The Types covered in the Natural Killer (NK) Cell Therapeutics Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

Recommended Reports

Cell Therapy Immunotherapy

NK & CAR-T Therapy

Cancer Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Mogamulizumab

1.2.3 Lorvotuzumab Mertansine

1.2.4 Others

1.3 Market by Application

1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2020-2031)

2.2 Global Natural Killer (NK) Cell Therapeutics Growth Trends by Region

2.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Natural Killer (NK) Cell Therapeutics Market Dynamics

2.3.1 Natural Killer (NK) Cell Therapeutics Industry Trends

2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers

2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges

2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue

3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Natural Killer (NK) Cell Therapeutics Revenue

3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio

3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2024

3.5 Global Key Players of Natural Killer (NK) Cell Therapeutics Head office and Area Served

3.6 Global Key Players of Natural Killer (NK) Cell Therapeutics, Product and Application

3.7 Global Key Players of Natural Killer (NK) Cell Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type

4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2026-2031)

5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application

5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)

6.2 North America Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)

6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)

7.2 Europe Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)

7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)

9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Chipscreen Biosciences

11.1.1 Chipscreen Biosciences Company Details

11.1.2 Chipscreen Biosciences Business Overview

11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction

11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.1.5 Chipscreen Biosciences Recent Development

11.2 Affimed NV

11.2.1 Affimed NV Company Details

11.2.2 Affimed NV Business Overview

11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction

11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.2.5 Affimed NV Recent Development

11.3 Altor BioScience

11.3.1 Altor BioScience Company Details

11.3.2 Altor BioScience Business Overview

11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction

11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.3.5 Altor BioScience Recent Development

11.4 Innate Pharma

11.4.1 Innate Pharma Company Details

11.4.2 Innate Pharma Business Overview

11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction

11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.4.5 Innate Pharma Recent Development

11.5 Takeda

11.5.1 Takeda Company Details

11.5.2 Takeda Business Overview

11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction

11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.5.5 Takeda Recent Development

11.6 Sorrento Therapeutics

11.6.1 Sorrento Therapeutics Company Details

11.6.2 Sorrento Therapeutics Business Overview

11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction

11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.6.5 Sorrento Therapeutics Recent Development

11.7 NantKwest

11.7.1 NantKwest Company Details

11.7.2 NantKwest Business Overview

11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction

11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.7.5 NantKwest Recent Development

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Details

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction

11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.8.5 Bristol-Myers Squibb Recent Development

11.9 NKT

11.9.1 NKT Company Details

11.9.2 NKT Business Overview

11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction

11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.9.5 NKT Recent Development

11.10 Henry Ford Health Services

11.10.1 Henry Ford Health Services Company Details

11.10.2 Henry Ford Health Services Business Overview

11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction

11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

11.10.5 Henry Ford Health Services Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Chipscreen Biosciences

Affimed NV

Altor Bioscience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

List of Tables

Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Mogamulizumab

Table 3. Key Players of Lorvotuzumab Mertansine

Table 4. Key Players of Others

Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2020-2025)

Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2026-2031)

Table 11. Natural Killer (NK) Cell Therapeutics Market Trends

Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers

Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges

Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints

Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Natural Killer (NK) Cell Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2024)

Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Natural Killer (NK) Cell Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Natural Killer (NK) Cell Therapeutics, Product and Application

Table 22. Global Key Players of Natural Killer (NK) Cell Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Chipscreen Biosciences Company Details

Table 48. Chipscreen Biosciences Business Overview

Table 49. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product

Table 50. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Chipscreen Biosciences Recent Development

Table 52. Affimed NV Company Details

Table 53. Affimed NV Business Overview

Table 54. Affimed NV Natural Killer (NK) Cell Therapeutics Product

Table 55. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Affimed NV Recent Development

Table 57. Altor BioScience Company Details

Table 58. Altor BioScience Business Overview

Table 59. Altor BioScience Natural Killer (NK) Cell Therapeutics Product

Table 60. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Altor BioScience Recent Development

Table 62. Innate Pharma Company Details

Table 63. Innate Pharma Business Overview

Table 64. Innate Pharma Natural Killer (NK) Cell Therapeutics Product

Table 65. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Innate Pharma Recent Development

Table 67. Takeda Company Details

Table 68. Takeda Business Overview

Table 69. Takeda Natural Killer (NK) Cell Therapeutics Product

Table 70. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Takeda Recent Development

Table 72. Sorrento Therapeutics Company Details

Table 73. Sorrento Therapeutics Business Overview

Table 74. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product

Table 75. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Sorrento Therapeutics Recent Development

Table 77. NantKwest Company Details

Table 78. NantKwest Business Overview

Table 79. NantKwest Natural Killer (NK) Cell Therapeutics Product

Table 80. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 81. NantKwest Recent Development

Table 82. Bristol-Myers Squibb Company Details

Table 83. Bristol-Myers Squibb Business Overview

Table 84. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product

Table 85. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Bristol-Myers Squibb Recent Development

Table 87. NKT Company Details

Table 88. NKT Business Overview

Table 89. NKT Natural Killer (NK) Cell Therapeutics Product

Table 90. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 91. NKT Recent Development

Table 92. Henry Ford Health Services Company Details

Table 93. Henry Ford Health Services Business Overview

Table 94. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product

Table 95. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Henry Ford Health Services Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Natural Killer (NK) Cell Therapeutics Picture

Figure 2. Global Natural Killer (NK) Cell Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Mogamulizumab Features

Figure 5. Lorvotuzumab Mertansine Features

Figure 6. Others Features

Figure 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Cancer Case Studies

Figure 10. Cardiovascular Diseases Case Studies

Figure 11. Others Case Studies

Figure 12. Natural Killer (NK) Cell Therapeutics Report Years Considered

Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Natural Killer (NK) Cell Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2024

Figure 17. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2024

Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Natural Killer (NK) Cell Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2020-2031)

Figure 33. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 49. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 50. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 51. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 52. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 53. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 54. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 56. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 57. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Natural Killer Cell Therapy Market Insights Forecast to 2030

Global NK Cell Therapy Market Insights Forecast to 2030

Global Natural Killer Cell Therapeutics Market Research Report 2024

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Engineered Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Therapy Market Insights Forecast to 2030

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Global Cell and Gene Therapy Market Research Report 2024

Global Personalized Cell Therapy Market Research Report 2024

Global Immune Cell Therapy Drugs Market Research Report 2025

Global Immunocell Therapy Market Insights Forecast to 2030

Global Cell therapy platform Market Research Report 2024

Global Cellular Therapy Products Market Research Report 2024

Global Universal Cell Therapy Drug Market Research Report 2024

Global Autologous Cell Therapy Products Market Research Report 2024

Global Immuno oncology Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions